Skip to content
  • Why X-Chem
    • Our Difference
    • Discovery Philosophy
    • Chemomics
  • Insights & Results
    • Resource Center
      • All Resources
      • Case Studies
      • Press Releases
      • Scientific Posters
      • Scientific Publications
    • News
    • Target Classes
      • Protein-Protein Interactions
      • Targeted Protein Degradation Molecular Glues
      • Covalent Inhibitors
      • Kinases
      • GPCR Discovery
    • DEL Track Record
    • MedChem Track Record
  • Ways to Partner
    • Flexible Project Models
      • CandidateBuilder
      • HitBuilder
      • LeadBuilder
    • Fee for Service Packages
    • Platform Enablement
    • Strategic Collaborations
  • Our Technology
    • DEL Screening
    • Medicinal & Synthetic Chemistry
    • Research Products
    • Computational Sciences
  • About Us
    • Leadership
    • History
    • Careers
      • Why X-Chem
      • Job Opportunities
  • Contact Us
get in touch
  • Why X-Chem
    • Our Difference
    • Discovery Philosophy
    • Chemomics
  • Insights & Results
    • Resource Center
      • All Resources
      • Case Studies
      • Press Releases
      • Scientific Posters
      • Scientific Publications
    • News
    • Target Classes
      • Protein-Protein Interactions
      • Targeted Protein Degradation Molecular Glues
      • Covalent Inhibitors
      • Kinases
      • GPCR Discovery
    • DEL Track Record
    • MedChem Track Record
  • Ways to Partner
    • Flexible Project Models
      • CandidateBuilder
      • HitBuilder
      • LeadBuilder
    • Fee for Service Packages
    • Platform Enablement
    • Strategic Collaborations
  • Our Technology
    • DEL Screening
    • Medicinal & Synthetic Chemistry
    • Research Products
    • Computational Sciences
  • About Us
    • Leadership
    • History
    • Careers
      • Why X-Chem
      • Job Opportunities
  • Contact Us
get in touch

2020

2020

  • 2020, Press Releases

    X‑Chem Announces Achievement of Milestone In Orexia Collaboration

    Download PDF Waltham, Mass – July 22, 2020 [...]

  • 2020, Press Releases

    Study Published in the Journal of Medicinal Chemistry Demonstrates the Power of Machine Learning to Unlock New Chemistry and Biology to Treat Disease

    Download PDF Study Published in the Journal of [...]

  • 2020, Press Releases

    GHO Capital Acquires X‑Chem, the Leading Provider of DNA-Encoded-Library-Mediated Drug Discovery Services

    Download PDF  Matt Clark named new Chief Executive [...]

  • 2020, Press Releases

    X‑Chem Announces Licensing of a Drug Discovery Program to Otsuka

    Download PDF Waltham, Mass – May 20, 2020 [...]

  • 2020, Press Releases

    ALK-Abelló and X‑Chem Announce Drug Discovery Collaboration

    WALTHAM, Mass. – February 5, 2019 – X-Chem, Inc. [...]

  • 2020, Press Releases

    ZebiAI Therapeutics, Inc. and X‑Chem Enter into Strategic Agreement to Enable Validation of Novel Therapeutic Targets and Acceleration of Drug Candidate Discovery

    Download PDF New venture capital-backed artificial intelligence company [...]

Back to Resource Center
North America
Europe

United States

X-Chem Global HQ
100 Beaver Street
Waltham, MA 02453
United States
Map

Canada

X-Chem Canada
4800 Rue Levy
Montreal, QC H4R 2P1
Canada
Map

Hungary

X-Chem Europe
Graphisoft Park (Building D)
1031 Budapest, Záhony u. 7.
Hungary
Map

Terms & Conditions

© 2025 X-Chem, Inc. • All Rights Reserved

Sign-up for Our Newsletter

Be first to see what’s next in drug discovery.

X-Chem may contact you with relevant updates. Unsubscribe anytime. See our Privacy Policy.

Terms & Conditions

© 2025 X-Chem, Inc. • All Rights Reserved

Page load link
  • Why X-Chem
    • Our Difference
    • Discovery Philosophy
    • Chemomics
  • Insights & Results
    • Resource Center
      • All Resources
      • Case Studies
      • Press Releases
      • Scientific Posters
      • Scientific Publications
    • News
    • Target Classes
      • Protein-Protein Interactions
      • Targeted Protein Degradation Molecular Glues
      • Covalent Inhibitors
      • Kinases
      • GPCR Discovery
    • DEL Track Record
    • MedChem Track Record
  • Ways to Partner
    • Flexible Project Models
      • CandidateBuilder
      • HitBuilder
      • LeadBuilder
    • Fee for Service Packages
    • Platform Enablement
    • Strategic Collaborations
  • Our Technology
    • DEL Screening
    • Medicinal & Synthetic Chemistry
    • Research Products
    • Computational Sciences
  • About Us
    • Leadership
    • History
    • Careers
      • Why X-Chem
      • Job Opportunities
  • Contact Us
P : +1 781.419.6900
Email Us
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
Go to Top